RU2011138818A - Method for transurethral resection of the prostate, preceding prostate cancer brachytherapy - Google Patents

Method for transurethral resection of the prostate, preceding prostate cancer brachytherapy Download PDF

Info

Publication number
RU2011138818A
RU2011138818A RU2011138818/14A RU2011138818A RU2011138818A RU 2011138818 A RU2011138818 A RU 2011138818A RU 2011138818/14 A RU2011138818/14 A RU 2011138818/14A RU 2011138818 A RU2011138818 A RU 2011138818A RU 2011138818 A RU2011138818 A RU 2011138818A
Authority
RU
Russia
Prior art keywords
prostate
transurethral resection
prostate cancer
cancer brachytherapy
gland
Prior art date
Application number
RU2011138818/14A
Other languages
Russian (ru)
Other versions
RU2519407C2 (en
Inventor
Виктор Павлович Горелов
Сергей Игоревич Горелов
Original Assignee
Виктор Павлович Горелов
Сергей Игоревич Горелов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Виктор Павлович Горелов, Сергей Игоревич Горелов filed Critical Виктор Павлович Горелов
Priority to RU2011138818/14A priority Critical patent/RU2519407C2/en
Publication of RU2011138818A publication Critical patent/RU2011138818A/en
Application granted granted Critical
Publication of RU2519407C2 publication Critical patent/RU2519407C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

Способ трансуретральной резекции предстательной железы, предшествующий брахитерапии рака простаты, состоящий в уменьшении объема железы и формировании оптимального просвета мочеиспускательного канала, отличающийся тем, что осуществляют полное удаление тканей средней доли простаты и области шейки мочевого пузыря.The method of transurethral resection of the prostate gland prior to prostate cancer brachytherapy, which consists in reducing the volume of the gland and forming the optimal lumen of the urethra, characterized in that the tissues of the middle lobe of the prostate and the bladder neck are completely removed.

Claims (1)

Способ трансуретральной резекции предстательной железы, предшествующий брахитерапии рака простаты, состоящий в уменьшении объема железы и формировании оптимального просвета мочеиспускательного канала, отличающийся тем, что осуществляют полное удаление тканей средней доли простаты и области шейки мочевого пузыря. The method of transurethral resection of the prostate gland prior to prostate cancer brachytherapy, which consists in reducing the volume of the gland and forming the optimal lumen of the urethra, characterized in that the tissues of the middle lobe of the prostate and the bladder neck are completely removed.
RU2011138818/14A 2011-09-21 2011-09-21 Method for transurethral prostatic resection preceding brachytherapy of prostate cancer RU2519407C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2011138818/14A RU2519407C2 (en) 2011-09-21 2011-09-21 Method for transurethral prostatic resection preceding brachytherapy of prostate cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2011138818/14A RU2519407C2 (en) 2011-09-21 2011-09-21 Method for transurethral prostatic resection preceding brachytherapy of prostate cancer

Publications (2)

Publication Number Publication Date
RU2011138818A true RU2011138818A (en) 2013-03-27
RU2519407C2 RU2519407C2 (en) 2014-06-10

Family

ID=49124070

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011138818/14A RU2519407C2 (en) 2011-09-21 2011-09-21 Method for transurethral prostatic resection preceding brachytherapy of prostate cancer

Country Status (1)

Country Link
RU (1) RU2519407C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2757678C1 (en) * 2021-02-10 2021-10-20 Евгений Николаевич Болгов Method for preventing injury to the external urethral sphincter when performing transurethral laser enucleation of benign prostatic hyperplasia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2404747C2 (en) * 2005-03-31 2010-11-27 Лиддс Аб Method for treatment of prostate gland diseases based on local delivery of active materials

Also Published As

Publication number Publication date
RU2519407C2 (en) 2014-06-10

Similar Documents

Publication Publication Date Title
EA201290901A1 (en) PHYTOCANNABINOIDS FOR THE TREATMENT OF MALIGNANT TUMOR
IN2012DN02046A (en)
NZ598791A (en) Anti-gcc antibody molecules and related compositions and methods
EA201201186A1 (en) USE OF ERBB3 INHIBITORS IN THE TREATMENT OF NEGATIVE AND BASAL-LIKE BREAST CANCER TREATMENT
BR112014031421A2 (en) cancer treatment compositions and methods for producing them
EA201101522A1 (en) METHODS OF TREATMENT OF DISEASES WITH THE USE OF EPIMETABOLIC SWITCH (COENZIM Q10)
WO2013003112A9 (en) Methods and compositions for treatment of cancer and autoimmune disease
WO2015009726A3 (en) Medical uses of cd38 agonists
PH12018502570A1 (en) Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
MX363243B (en) Compositions and methods for treating cancer.
AR082340A1 (en) METHODS AND COMPOSITIONS FOR LIVER CANCER THERAPY
NZ622505A (en) Therapeutic compounds and compositions
EA201490194A1 (en) COMBINED THERAPY, INCLUDING CDK4 / 6 INHIBITOR AND PI3K INHIBITOR FOR USE IN CANCER TREATMENT
EA200901074A1 (en) TREATMENT OF THE METASTATIC STAGE OF PROSTATE CANCER WITH DEGARELIX
PH12014501639A1 (en) Pharmaceutical compositions and methods
AR087918A1 (en) COMBINED TREATMENTS INCLUDING C-MET ANTAGONISTS AND B-RAF ANTAGONISTS
WO2011130164A3 (en) Unconjugated anti-tfr antibodies and compositions thereof for the treatment of cancer
DK2252322T3 (en) vaccine Compositions
ECSP14013195A (en) CATHETER, IN PARTICULAR PERMANENT CATHETER FOR THE TREATMENT OF DYSFUNCTIONS AND / OR DISEASES OF THE BLADDER AND / OR THE PROSTATE.
MX2023000191A (en) Methods of making and using pde9 inhibitors.
MY176599A (en) Treatment of prostate cancer with tor kinase inhibitors
CL2011002812A1 (en) Compounds derived from [1,2,4] triazolo [4,3-b] pyridazines; Preparation process; and use in the treatment of prostate cancer.
WO2013188715A3 (en) Compositions and methods for treating cancer
EA201391438A1 (en) DERIVATIVES OF SULINDAC, APPLICATION AND OBTAINING OF THE INDICATED DERIVATIVES
MX2010004259A (en) Improved antitumoral treatments.

Legal Events

Date Code Title Description
HE9A Changing address for correspondence with an applicant
MM4A The patent is invalid due to non-payment of fees

Effective date: 20140922